Last deal

$15M

Amount

Series A

Stage

10.10.2023

Date

24

all rounds

$20.7M

Total amount

General

About Company
NERv utilizes body data to detect post-operative complications early.

Industry

Sector :

Subsector :

Keywords :

founded date

29.05.2014

Number of employees

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

NERv's platform sensing technology enhances existing medical devices to provide smart monitoring for healthcare providers, aiming to decrease response time to potential complications and improve patient recovery. Co-founded by University of Waterloo Engineering graduates, NERv is developing sensors and predictive models to detect complications at their onset, with the goal of preventing patient fatalities due to undetected post-operative complications.
Contacts

Phone number

Social url